Global Bioenergies secures order from Shell for testing biobased isobutene derivatives
Type of post: NEWS IN BRIEF.
Global Bioenergies has received its first order from Shell, to provide volumes of bio-isobutene derivatives for performance assessment.
Press release: "Global Bioenergies secures first order from Shell for testing volumes of bio-isobutene derivatives", 21/06/2022.
Related posts: "Global Bioenergies takes a major step towards scaling up its isobutene production process", 24/05/2021.
Global Bioenergies has focused its strategy on the bioproduction of isobutene as this molecule is one of the main building blocks in the world of chemistry. Its derivatives can be used in a wide range of sectors from cosmetics and fine chemicals to commodities and fuels. The global market of isobutene reaches 15 million tons per year.
Shell plans to explore the possibility of replacing current hydrocarbon-based isobutene and its derivatives with their equivalents from renewable resources, while maintaining the same level of performance. Global Bioenergies brings ready-to-use solutions to industrialists in numerous areas. Such a switch to renewable isobutene could, in the future, allow for up to 70% less CO2 emissions compared to the hydrocarbon-based equivalent.